Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.

Clinica chimica acta; international journal of clinical chemistry - 15 Jun 2015

Xu Rui-Xia, Zhang Yan, Li Xiao-Lin, Li Sha, Guo Yuan-Lin, Dong Qian, Liu Geng, Li Jian-Jun

Abstract excerpt

BACKGROUND: Both increased lipoprotein-associated phospholipase A2 (Lp-PLA2) concentrations and atherogenic lipoprotein subfractions have been shown to reflect unfavourable cardiovascular risk. However, the correlation between Lp-PLA2 and lipoprotein subfractions in patients with coronary artery...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 1-Alkyl-2-acetylglycerophosphocholine Esterase
Share to Apolipoprotein A-I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins B

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Coronary Angiography

Share to Patient Selection

Share to Triglycerides

Source

Identifiers

PMID: 25934512
DOI: 10.1016/j.cca.2015.04.032

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25934512-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.PMID 25934512Read ↗

Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.Semantic proximity Read ↗

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.Semantic proximity Read ↗

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.Semantic proximity Read ↗

Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.Semantic proximity Read ↗

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?Semantic proximity Read ↗

Role of Lipoprotein(a) Reduction in Cardiovascular DiseaseSemantic proximity Read ↗

High-density lipoprotein subfractions--what the clinicians need to know.Semantic proximity Read ↗

Additive Antiatherogenic Effects of CETP rs708272 on Serum LDL Subfraction Levels in Patients with CHD Under Statin Therapy.Semantic proximity Read ↗

Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart DiseaseSemantic proximity Read ↗

The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events.Semantic proximity Read ↗

Impact of Lipoprotein (a) on Residual Cardiovascular Risk after an Acute Coronary SyndromeSemantic proximity Read ↗

Lipoprotein(a) cascade screening in coronary artery disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.